CytomX Therapeutics, Inc.CTMXNASDAQ
Loading
Interest Income Over TimeContracting
Percentile Rank67
3Y CAGR+45.8%
5Y CAGR+23.2%
Studio
Year-over-Year Change

Income earned from interest-bearing assets

3Y CAGR
+45.8%/yr
vs -31.5%/yr prior
5Y CAGR
+23.2%/yr
Recent acceleration
Acceleration
+77.4pp
Accelerating
Percentile
P67
Within normal range
vs 5Y Ago
2.8x
Strong expansion
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$5.21M-27.0%
2024$7.14M-27.5%
2023$9.84M+486.2%
2022$1.68M+558.0%
2021$255000.00-86.1%
2020$1.84M-78.1%
2019$8.37M+9.5%
2018$7.64M+185.8%
2017$2.67M+10.3%
2016$2.42M-